Dynamic albumin values as clinical surrogate for COVID-19 therapeutics.

van Zyl, Johanna S; Felius, Joost; Alam, Amit; Hall, Shelley A; Jamil, Aayla K; Spak, Cedric W; Gottlieb, Robert L

van Zyl, Johanna S; Felius, Joost; Alam, Amit; Hall, Shelley A; Jamil, Aayla K; Spak, Cedric W; Gottlieb, Robert L.

Afiliación

van Zyl JS; Baylor Scott & White Research Institute, Baylor Scott & White Health, Dallas, Texas, USA.
Felius J; Texas A&M University Health Science Center, Dallas, Texas, USA.
Alam A; Baylor Scott & White Research Institute, Baylor Scott & White Health, Dallas, Texas, USA.
Hall SA; Texas A&M University Health Science Center, Dallas, Texas, USA.
Jamil AK; Texas A&M University Health Science Center, Dallas, Texas, USA.
Spak CW; Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, Texas, USA.
Gottlieb RL; Division of Cardiology, Baylor University Medical Center, Dallas, TX, USA.

J Investig Med ; 69(6): 1260, 2021 08.

Article en En | MEDLINE | ID: mdl-34050000

Asunto(s)

COVID-19; Albúmina Sérica; Proteínas de Fase Aguda; Humanos; Estudios Retrospectivos; SARS-CoV-2

Palabras clave

COVID-19; inflammation; serum albumin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Albúmina Sérica / COVID-19 Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: J Investig Med Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google